High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F] fluorodihydroxyphenylalanine PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 6, 2013, Pages 889-896

  Miederer, Matthias ^a   Fottner, Christian ^a   Rossmann, Heidi ^a   Helisch, Andreas ^a   Papaspyrou, Konstantinos ^a   Bartsch, Oliver ^a   Mann, Wolf J ^a   Musholt, Thomas J ^b   Weber, Matthias M ^a   Lackner, Karl J ^a   Schreckenberger, Mathias ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Familiar paraganglioma syndrome; FDOPA; Positron emission tomography; SDHD mutation

Indexed keywords

FLUORODIHYDROXYPHENYLALANINE F 18; RADIOPHARMACEUTICAL AGENT; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; 6 FLUORODOPA F 18; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; COMPLEX II DEFICIENCY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC DISORDER; HEREDITARY PARAGANGLIOMA SYNDROME; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PARAGANGLIOMA; PET SCANNER; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; RARE DISEASE; RELATIVE; RETROSPECTIVE STUDY; CHEMODECTOMA; CHILD; GENETICS; INCIDENCE; LABORATORY DIAGNOSIS; MIDDLE AGED; MULTIMODAL IMAGING; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; SYNDROME; YOUNG ADULT; ANALOGS AND DERIVATIVES; DIAGNOSTIC USE; GERMLINE MUTATION; PARAGANGLIOMA, EXTRA-ADRENAL;

ADOLESCENT; ADULT; CHILD; DIHYDROXYPHENYLALANINE; FALSE NEGATIVE REACTIONS; FEMALE; GERM-LINE MUTATION; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MUTATION; PARAGANGLIOMA, EXTRA-ADRENAL; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SUCCINATE DEHYDROGENASE; SYNDROME; YOUNG ADULT;

EID: 84886717576     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2346-6     Document Type: Article

References (10)

1. Fliedner SM, Lehnert H, Pacak K. Metastatic paraganglioma. Semin Oncol. 2010;37:627-37. doi:10.1053/j.seminoncol.2010.10.017.
2. Musholt TJ. Diagnosis of and surgical therapy for pheochromocytoma and paraganglioma. Zentralbl Chir. 2010;135:226-32. doi:10.1055/s-0030-1247315.
3. Papaspyrou K, Mewes T, Rossmann H, Fottner C, Schneider- Raetzke B, Bartsch O, et al. Head and neck paragangliomas: report of 175 patients (1989-2010). Head Neck. 2012;34:632-7. doi:10.1002/hed.21790.
4. Dziegielewski PT, Knox A, Liu R, Hung RW, Harris J. Familial paraganglioma syndrome: applying genetic screening in otolaryngology. J Otolaryngol Head Neck Surg. 2010;39:646-53.
5. van Duinen N, Steenvoorden D, Bonsing BA, Vuyk J, Vriends AH, Jansen JC, et al. Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms. Eur J Endocrinol. 2010;163:121-7. doi:10.1530/EJE- 10-0114.
6. Taieb D, Timmers HJ, Hindie E, Guillet BA, Neumann HP, Walz MK, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1977-95. doi:10.1007/s00259- 012-2215-8.
7. 18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. J Clin Endocrinol Metab. 2010;95:2800-10. doi:10.1210/jc.2009-2352.
8. 18F-fluoro-2-deoxy-D-glucose PET, 123Imetaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab. 2011;96:2779-85. doi:10.1210/jc.2011-0333.
9. 18F-fluoro-L-phenylalanin PET. J Nucl Med. 2012;53:1352-8. doi:10.2967/jnumed.111.101303.
10. Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011;96:717-25. doi:10.1210/jc.2010-1946.